Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | ANR9OP1V17 |
InChI Key | GTUIQNHJSXQMKW-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C11H13ClN2O2 |
Molecular Weight | 240.69 |
AlogP | 1.22 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 45.48 |
Molecular species | BASE |
Aromatic Rings | 1.0 |
Heavy Atoms | 16.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Neuronal acetylcholine receptor; alpha4/beta2 agonist | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
5HT3 receptor
|
- | - | - | 700 | 87 | |
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
4900-4900 | - | - | 30-30 | - | |
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor beta subunit
|
4900-4900 | - | - | 30-30 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alzheimer Disease | 2 | D000544 | ClinicalTrials |
Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL2179529 |
FDA SRS | ANR9OP1V17 |
SureChEMBL | SCHEMBL584395 |